XELJANZ is the first in a class of treatments for moderate to severe RA called Janus kinase (JAK) inhibitors. It is the #1 prescribed JAK inhibitor for moderate to severe RA. If methotrexate hasn’t done enough to help relieve your RA symptoms, and before you and your rheumatologist decide on a biologic, ask if XELJANZ is right for you.

Taxonomy: